Concomitant therapy with prednisolone and cyclophosphamide in 17 cases with IgA nephropathy
Katsumata, Y.; Hasegawa, K.; Hoshino, K.
Nihon Jinzo Gakkai Shi 27(3): 295-302
1985
ISSN/ISBN: 0385-2385 PMID: 4021193 Document Number: 263124
Document emailed within 1 workday
Related Documents
Uzuka, Y.; Saito, Y.; Takahashi, H.; Komatsu, M.; Ito, T. 1989: Combination chemotherapy of multiple myeloma--BCNU.cyclophosphamide.procarbazine.prednisolone and MCNU.cyclophosphamide.procarbazine.prednisolone therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(6): 2269-2273Bezwoda, W.R.; Rastogi, R.B. 1994: A randomized comparative study of cyclophosphamide, vincristine, doxorubicin, and prednisolone and cyclophosphamide, vincristine, mitoxantrone, and prednisolone regimens in the treatment of intermediate- and high-grade lymphoma with 8 years' follow-up Seminars in Hematology 31(2 Suppl 3: 3
Li, X.; Lv, R.; He, Q.; Li, H.; Du, X.; Lin, W.; Li, Q.; He, X.; Wang, S.; Chen, J. 2008: Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria Journal of Nephrology 21(4): 584-591
Umsawasdi, T.; Nilprabhassorn, P. 1978: Combination chemotherapy with cyclophosphamide (NSC-26 271), methotrexate (NSC-740), and prednisolone (NSC-9 900) (CMP protocol), for metastatic breast cancer Journal of the Medical Association of Thailand 61(3): 158-161
Raevskiĭ, I.G. 1976: Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone Sovetskaia Meditsina 8: 112-114
Kanzler, S.; Gerken, G.; Dienes, H.P.; Meyer zum Büschenfelde, K.H.; Lohse, A.W. 1997: Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases Zeitschrift für Gastroenterologie 35(7): 571-578
Mizuno, H.; Ninomiya, N.; Ohta, H.; Tokoro, K.; Yasuma, A.; Ohnishi, K.; Ikeda, Y. 1983: Treatment of multiple myeloma. High-dose intermittent administration of cyclophosphamide and prednisolone--follow up study of 10 years period Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(11): 2286-2291
Kobayashi, Y.; Hiki, Y.; Fujii, K.; Kurokawa, A.; Kamiyana, M.; Tateno, S. 1987: IgA nephropathy: heterogeneous clinical pictures and steroid therapy in progressive cases Seminars in Nephrology 7(4): 382-385
Kihara, M.; Kontani, K.; Yamauchi, A.; Yokomise, H. 2005: Two cases of advanced breast cancer responding to oral chemoendocrine therapy with 5'-deoxy-5-fluorouridine, medroxyprogesterone acetate and cyclophosphamide (DMpC) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(5): 683-686
Jardine, I.; Fenselau, C.; Appler, M.; Kan, M.N.; Brundrett, R.B.; Colvin, M. 1978: Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy Cancer Research 38(2): 408-415
Fang, J.; Li, W.; Li, D.; Tan, Z. 2014: Baseline proteinuria, urinary osmotic pressure, and renal function as positive predictors of corticosteroids plus cyclophosphamide treatment efficacy in IgA nephropathy Chinese Medical Journal 127(9): 1710-1714
Nakamura, T.; Fujikura, Y.; Suga, N.; Hatazoe, K.; Hinoshita, F. 2006: An IgA nephropathy case with highly reduced urinary protein concomitant with reduced obesity Nihon Jinzo Gakkai Shi 48(7): 675-679
Miyamae, T.; Nakasima, S.; Imagawa, T.; Ito, S.; Katakura, S.; Tomono, N.; Mori, M.; Ibe, M.; Mitsuda, T.; Aihara, Y.; Yokota, S. 1999: Improvement of the maintenance therapy after methylprednisolone pulse therapy--effect of prednisolone combined with immunosuppressants Ryumachi 39(6): 829-835
Błaszczak, R.; Kujawski, K.; Kedziora-Kornatowska, K.; Kornatowski, T.; Kedziora, J.óz.; Szadujkis-Szadurski, L.; Markuszewski, L.; Rysz, J.; Ertel, D.; Olszewski, R. 2005: The total antioxidant capacity and low-molecular antioxidant concentration in plasma of type-2 diabetes patients with different stage of metabolic compensation and concomitant diabetic nephropathy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 18(103): 29-32
Shahidullah, M.; Haque, A.; Islam, M.R.; Rizvi, A.N.; Sultana, N.; Mia, B.A.; Hussain, M.A. 2011: Comparative study between combination of famciclovir and prednisolone with prednisolone alone in acute Bell's palsy Mymensingh Medical Journal: Mmj 20(4): 605-613
Izumi, T.; Muroi, K.; Hoshino, Y.; Komatsu, N.; Ohtsuki, T.; Yamada, M.; Tomizuka, H.; Hatake, K.; Furusawa, S.; Miura, Y. 1996: Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 797-800
Oka, K.; Shimodaira, H.; Hirano, T.; Sakurai, E.; Tamaki, T.; Kozaki, M. 1993: Comparison of adrenal functions in kidney transplant recipients with different long-term immunosuppressive treatments--prednisolone and azathioprine versus prednisolone and cyclosporine Transplantation 56(3): 603-609
Gushcha, A.L.; Krylov, I.F. 1978: Intraperitoneal administration of prednisolone in the overall therapy of peritonitis Klinicheskaia Khirurgiia 1: 34-38
Bitaudeau, P.; Clément, S.; Chartier, J.P.; Papapietro, P.M.; Bonnafoux, A.; Arnaud, M.; Trèves, R.; Desproges-Gotteron, R. 1989: Interaction of rifampicin and prednisolone. Apropos of 2 cases occurring in Horton's disease Revue du Rhumatisme et des Maladies Osteo-Articulaires 56(1): 87-88
Vojniković, B.; Spanjol, J. 2007: Prednisolone neuroprotective therapy in age-related macular degeneration Collegium Antropologicum 31(Suppl 1): 69-70